JP2016512693A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016512693A5 JP2016512693A5 JP2016503010A JP2016503010A JP2016512693A5 JP 2016512693 A5 JP2016512693 A5 JP 2016512693A5 JP 2016503010 A JP2016503010 A JP 2016503010A JP 2016503010 A JP2016503010 A JP 2016503010A JP 2016512693 A5 JP2016512693 A5 JP 2016512693A5
- Authority
- JP
- Japan
- Prior art keywords
- reagent
- providing
- cell
- tissue sample
- chaotrope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361798627P | 2013-03-15 | 2013-03-15 | |
| US61/798,627 | 2013-03-15 | ||
| PCT/US2014/029198 WO2014144682A1 (en) | 2013-03-15 | 2014-03-14 | Methods and reagents for maintaining the viability of cancer cells in surgically removed tissue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016512693A JP2016512693A (ja) | 2016-05-09 |
| JP2016512693A5 true JP2016512693A5 (https=) | 2017-04-13 |
| JP6465857B2 JP6465857B2 (ja) | 2019-02-06 |
Family
ID=51528685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016503010A Active JP6465857B2 (ja) | 2013-03-15 | 2014-03-14 | 外科的に摘出された組織における癌細胞の生存能を維持するための方法および試薬 |
Country Status (17)
| Country | Link |
|---|---|
| US (5) | US9113623B2 (https=) |
| EP (2) | EP2970878B1 (https=) |
| JP (1) | JP6465857B2 (https=) |
| CN (2) | CN112806352A (https=) |
| CA (1) | CA2941929C (https=) |
| CY (1) | CY1120801T1 (https=) |
| DK (1) | DK2970878T3 (https=) |
| ES (1) | ES2684582T3 (https=) |
| HR (1) | HRP20181352T1 (https=) |
| HU (1) | HUE039933T2 (https=) |
| LT (1) | LT2970878T (https=) |
| PL (1) | PL2970878T3 (https=) |
| PT (1) | PT2970878T (https=) |
| RS (1) | RS57900B1 (https=) |
| SI (1) | SI2970878T1 (https=) |
| SM (1) | SMT201800457T1 (https=) |
| WO (1) | WO2014144682A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2970878T (lt) | 2013-03-15 | 2018-11-12 | Truckee Applied Genomics, Llc | Vėžio ląstelių chirurginiu būdu pašalintame audinyje gyvybingumo palaikymo būdai ir reagenatai |
| US10053676B2 (en) | 2014-11-25 | 2018-08-21 | Bio-Rad Laboratories, Inc. | Arginine improves polymerase storage stability |
| CN107333750A (zh) * | 2017-06-11 | 2017-11-10 | 成都吱吖科技有限公司 | 一种长时血液细胞稳定剂 |
| WO2021055170A1 (en) * | 2019-09-17 | 2021-03-25 | Longhorn Vaccines And Diagnostics, Llc | Multipurpose compositions for collecting and transporting biological material |
| WO2022010916A1 (en) * | 2020-07-07 | 2022-01-13 | Truckee Applied Genomics, Llc | Cell preservation reagents and methods of use |
| CN117063915B (zh) * | 2023-08-17 | 2026-02-24 | 镜像绮点(上海)细胞技术有限公司 | 原代肿瘤细胞冻存液 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5409826A (en) * | 1993-06-08 | 1995-04-25 | Coulter Corporation | Preserved, non-infectious control cells prepared by the modulation or modification of normal cells |
| CA2250570A1 (en) * | 1996-03-26 | 1997-10-02 | Eli Lilly And Company | Formulations of ob protein |
| US20010007673A1 (en) | 1999-11-12 | 2001-07-12 | Merrill Seymour Goldenberg | Sustained-release delayed gels |
| US7569342B2 (en) | 1997-12-10 | 2009-08-04 | Sierra Molecular Corp. | Removal of molecular assay interferences |
| US20080064108A1 (en) | 1997-12-10 | 2008-03-13 | Tony Baker | Urine Preservation System |
| WO1999029904A2 (en) | 1997-12-10 | 1999-06-17 | Sierra Diagnostics, Inc. | Methods and reagents for preservation of dna in bodily fluids |
| AU1848602A (en) * | 2000-12-04 | 2002-06-18 | Lymphotec Inc. | Cell-preservation liquid and method of preserving cells by using the liquid |
| KR20020066778A (ko) | 2001-02-13 | 2002-08-21 | 한국과학기술연구원 | 체내 난흡수 물질의 흡수촉진용 조성물과 제형 및 그의제조방법 |
| WO2008111981A1 (en) | 2007-03-14 | 2008-09-18 | Sierra Molecular Corporation | Compositions, systems, and methods for preservation of macromolecules |
| WO2004052184A2 (en) * | 2002-12-12 | 2004-06-24 | Oncotech, Inc. | Genes related to sensitivity and resistance to chemotherapeutic drug treatment |
| US8793895B2 (en) * | 2006-02-10 | 2014-08-05 | Praxair Technology, Inc. | Lyophilization system and method |
| US8652782B2 (en) * | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| US8080645B2 (en) * | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| WO2008033936A2 (en) | 2006-09-12 | 2008-03-20 | Sierra Molecular Corporation | Removal of molecular assay interferences for nucleic acids employing buffered solutions of chaotropes |
| WO2008052170A2 (en) | 2006-10-27 | 2008-05-02 | Sierra Molecular Corporation | Penetratable septum cap |
| WO2008071384A1 (en) | 2006-12-13 | 2008-06-19 | Roche Diagnostics Gmbh | Use of tde for the isolation of nucleic acids |
| KR20100015578A (ko) | 2007-03-14 | 2010-02-12 | 시에라 몰레큘러 코포레이션 | 세포 및/또는 거대분자의 보존 및/또는 안정화를 위한 조성물, 시스템 및 방법 |
| EP2217244A4 (en) * | 2007-11-12 | 2011-08-31 | Bipar Sciences Inc | TREATMENT OF NUTRITIONAL CANCER AND EGG CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTITUMOROUS MEDICINES |
| US20100003748A1 (en) | 2008-07-03 | 2010-01-07 | Tony Baker | Compositions, systems, and methods for stabilization of a cell and/or macromolecule |
| WO2010028156A2 (en) | 2008-09-04 | 2010-03-11 | Board Of Regents, The University Of Texas System | Dual modality detection of apoptosis |
| US9133343B2 (en) * | 2009-11-30 | 2015-09-15 | Enzo Biochem, Inc. | Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications |
| CN102318597B (zh) * | 2011-08-19 | 2013-04-03 | 张雪云 | 一种液基细胞保存液组合物及其制备方法 |
| LT2970878T (lt) | 2013-03-15 | 2018-11-12 | Truckee Applied Genomics, Llc | Vėžio ląstelių chirurginiu būdu pašalintame audinyje gyvybingumo palaikymo būdai ir reagenatai |
-
2014
- 2014-03-14 LT LTEP14763797.9T patent/LT2970878T/lt unknown
- 2014-03-14 EP EP14763797.9A patent/EP2970878B1/en active Active
- 2014-03-14 PT PT14763797T patent/PT2970878T/pt unknown
- 2014-03-14 HR HRP20181352TT patent/HRP20181352T1/hr unknown
- 2014-03-14 HU HUE14763797A patent/HUE039933T2/hu unknown
- 2014-03-14 CA CA2941929A patent/CA2941929C/en active Active
- 2014-03-14 SM SM20180457T patent/SMT201800457T1/it unknown
- 2014-03-14 CN CN202011428224.4A patent/CN112806352A/zh active Pending
- 2014-03-14 WO PCT/US2014/029198 patent/WO2014144682A1/en not_active Ceased
- 2014-03-14 JP JP2016503010A patent/JP6465857B2/ja active Active
- 2014-03-14 EP EP18173516.8A patent/EP3581643A1/en not_active Withdrawn
- 2014-03-14 PL PL14763797T patent/PL2970878T3/pl unknown
- 2014-03-14 ES ES14763797.9T patent/ES2684582T3/es active Active
- 2014-03-14 RS RS20180976A patent/RS57900B1/sr unknown
- 2014-03-14 US US14/211,578 patent/US9113623B2/en active Active
- 2014-03-14 CN CN201480014875.5A patent/CN105121629B/zh active Active
- 2014-03-14 DK DK14763797.9T patent/DK2970878T3/en active
- 2014-03-14 SI SI201430839T patent/SI2970878T1/sl unknown
-
2015
- 2015-05-01 US US14/702,643 patent/US9565852B2/en active Active
- 2015-05-14 US US14/712,750 patent/US9445586B2/en active Active
-
2016
- 2016-02-02 US US15/013,541 patent/US9949474B2/en active Active
-
2017
- 2017-02-13 US US15/431,478 patent/US10772318B2/en active Active
-
2018
- 2018-08-23 CY CY181100877T patent/CY1120801T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016512693A5 (https=) | ||
| PL3313991T3 (pl) | Modyfikowany czynnik ix oraz kompozycje, sposoby i zastosowania do transferu genów do komórek, narządów i tkanek | |
| BR112015017405A2 (pt) | composições que incluem agentes hidrofobizantes e estabilizantes e métodos para preparação e utilização das mesmas | |
| EP3310931A4 (en) | CRISPR / CAS9 COMPLEX FOR INTRODUCING A FUNCTIONAL POLYPEPTIDE IN CELLS OF A BLOOD CELL LINE | |
| HRP20260181T1 (hr) | Priprema i skladištenje lipozomskih rnk formulacija koje su pogodne za terapiju | |
| JP2016520647A5 (https=) | ||
| CL2016003324A1 (es) | Construcciones de anticuerpos multiespecificos. | |
| EP3564356A4 (en) | SOLUTION FOR CRYOPRESERVATION, CRYOGENIZATION PRODUCT, AND METHOD FOR CRYOPRESERVATION OF ANIMAL CELLS OR ANIMAL TISSUES | |
| BR112015021189A2 (pt) | métodos de banco de células de alta densidade | |
| JP2015061520A5 (https=) | ||
| NZ739339A (en) | Apoptosis signal-regulating kinase inhibitor | |
| PT2958913T (pt) | Agonistas de recetores de esfingosina-1-fosfato, métodos para a sua preparação e composições farmacêuticas que os contêm como agente ativo | |
| EA201691629A1 (ru) | Кристаллические твердые формы n-{4-[(6,7-диметоксихинолин-4-ил)окси]фенил}-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида, способы получения и способы применения | |
| AR090903A1 (es) | Anticuerpos e inmunoconjugados anti-pmel17 | |
| IL280962A (en) | Methods for delivering gene editing reagents to cells within organs | |
| WO2015153772A3 (en) | Zirconium-89 oxine complex as a cell labeling agent for positron emission tomography | |
| EP3202885A4 (en) | Novel biological activity testing structure for tracking single cell, using gelling agents | |
| EP3202409A4 (en) | Composition, cell construct, islet transplant kit, islet cell transplant therapeutic agent and blood sugar reducing agent, composition including islets, kit including islets, and islet transplant therapeutic agent and blood sugar reducing agent | |
| DK3079675T3 (da) | Farmaceutisk sammensætning indeholdende nikotinsyre og/eller nikotinamid til anvendelse til gavnlig påvirkning af blodlipidniveauer ved modificering af tarmmikrobiataen | |
| DK3232780T3 (da) | Vandige adjuvans-sammensætninger, der indeholder elektrolyt, sammensætninger, som indeholder et aktivt stof, og anvendelse deraf | |
| MX2013006188A (es) | Agentes de generacion de imagenes pet de apoptosis. | |
| MX389168B (es) | Procedimiento para preparar inhibidores de la glucosilceramida sintasa. | |
| BR112013021784A2 (pt) | composição de reagente, e, método para a recuperação de um metal de uma solução aquosa | |
| BR112017026666A2 (pt) | armazenagem de longo prazo e conservação de plaquetas | |
| EP3727585C0 (en) | SYSTEM FOR INDUCING SONOPERMEABILIZATION TRANSFER OF A DRUG INTO CANCER CELLS |